Tolvaptan for Fluid Management in Living Donor Liver Transplant Recipients

BACKGROUND: Tolvaptan, an antagonist of the vasopressin V2 receptor is a novel oral diuretic that promotes water excretion selectively. We have used furosemide as a primary diuretic and added human atrial natriuretic peptide (hANP) if necessary for fluid management postoperatively in living-donor li...

Descripción completa

Detalles Bibliográficos
Autores principales: Imai, Shunichi, Shinoda, Masahiro, Obara, Hideaki, Kitago, Minoru, Hibi, Taizo, Abe, Yuta, Yagi, Hiroshi, Matsubara, Kentaro, Higashi, Hisanobu, Itano, Osamu, Kitagawa, Yuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248066/
https://www.ncbi.nlm.nih.gov/pubmed/29311539
http://dx.doi.org/10.12659/AOT.905817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248066/
https://www.ncbi.nlm.nih.gov/pubmed/29311539
http://dx.doi.org/10.12659/AOT.905817

Ejemplares similares